The total return over the past 12 months is +14.42% vs. +16.94% for the S&P 500. So far it's up -32.77% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +14.42% | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | +14.42% | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Kyverna Therapeutics, Inc. (KYTX)
| Year | Start price | End price | KYTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $9.40 | $6.32 | (32.77%) | +14.51% | (47.28%) |
| 2025 | $3.74 | $9.40 | +151.34% | +17.72% | +133.62% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
